# Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2

> **NCT00000319** · PHASE2 · COMPLETED · sponsor: **Yale University**

## Conditions studied

- Opioid-Related Disorders
- Substance-Related Disorders

## Interventions

- **DRUG:** Buprenorphine

## Key facts

- **NCT ID:** NCT00000319
- **Lead sponsor:** Yale University
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 1996-06
- **Primary completion:** —
- **Final completion:** 2005-01
- **Target enrollment:** 0 (—)
- **Last updated:** 2020-07-07

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00000319

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00000319, "Buprenorphine Maintenance Dose Schedule and Treatment Setting - 2". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT00000319. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*